Enlivex Therapeutics Ltd. (ENLV) Social Stream
ENLIVEX THERAPEUTICS LTD (ENLV) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ENLIVEX THERAPEUTICS LTD.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-09 | 1 | $33 | $33 | $33 | $3.66 | 801.64% |
| 2023-08-01 | 1 | $15 | $15 | $15 | $3.66 | 309.84% |
| 2023-11-13 | 1 | $12 | $12 | $12 | $3.66 | 227.87% |
Price Target Last Issued March 9, 2022
The Trend in the Analyst Price Target
Over the past 35 months, ENLV's average price target has gone down $10.
ENLV reports an average of 464.43% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-23 | 1 | 15 | 15 | 15 | 4.200 | 257.14% |
| 2023-02-24 | 1 | 15 | 15 | 15 | 3.840 | 290.62% |
| 2023-08-01 | 1 | 15 | 15 | 15 | 2.685 | 458.66% |
| 2023-09-25 | 1 | 12 | 12 | 12 | 1.460 | 721.92% |
| 2023-11-13 | 1 | 12 | 12 | 12 | 1.750 | 585.71% |
ENLV Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 31 weeks, ENLV's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ENLV as an investment opportunity.
- In terms of how ENLIVEX THERAPEUTICS LTD fares relative to all US stocks, note that its number of analysts covering the stock is higher than nearly none of that group.
- In the context of all US stocks, ENLIVEX THERAPEUTICS LTD's variance in analysts' estimates is lower than nearly 100% of them.
- ENLIVEX THERAPEUTICS LTD's upside potential (average analyst target price relative to current price) is greater than 230.87% of Healthcare stocks.
- ENLV has a higher average analyst price target than 209.04% of stocks in the micro market cap category.
Stocks similar to ENLIVEX THERAPEUTICS LTD in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AKTX, HEPA, and LTRN.
View All Top Stocks by Price Target
Is ENLV a Buy, Hold or Sell? See the POWR Ratings now!